Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01455402 · ClinicalTrials.gov registry record
An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 476
- Enrollment target
NCT01455402: Completed study, sponsored by MedImmune.
NCT01455402 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 476 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01455402 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 476 participants
- Enrollment target
Study Summary
The primary objective of this observational study is to determine the incidence of medically attended (inpatient or outpatient) acute respiratory illnesses or events leading to worsening cardiorespiratory status (ie, acute exacerbations of chronic obstructive pulmonary disease \[AECOPD\] or worsening CHF) associated with RSV infections in high-risk adults (ie, those with severe COPD and/or advanced CHF) across multiple consecutive RSV seasons.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 476 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-05 |
What the finished NCT01455402 record still lists
NCT01455402 is an observational study that tracks outcomes without assigning an intervention. The registered 476 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01455402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01455402 about?
NCT01455402 is a clinical study titled "An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF". The primary objective of this observational study is to determine the incidence of medically attended (inpatient or outpatient) acute respiratory illnesses or events leading to worsening cardiorespiratory status (ie, acute exacerbations of chronic obstructive pulmonary disease \[AECOPD\] or worsenin...
What is the current status of trial NCT01455402?
This trial is currently completed. The enrollment target is 476 participants. The study started on 2010-07. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT01455402?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06754046 · 476 participants · NA
BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)
- NCT03911700 · 477 participants · NA
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
- NCT06997497 · 477 participants · Phase 3
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- NCT01788839 · 475 participants
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia